Please provide your email address to receive an email when new articles are posted on . Roche Diagnostics Corp. announced that the FDA has cleared its next-generation troponin T assay for use in ...
Results from the TRAPID-AMI clinical study have been published online by the Annals of Emergency Medicine, confirming a novel approach for a more rapid diagnosis of heart attack in patients with acute ...
US physicians who’ve been waiting to get their hands on high-sensitivity troponin tests don’t have to wait any longer. Last week, the US Food and Drug Administration (FDA) gave 510(k) clearance to the ...
Recently granted CE Mark, the novel test delivers improved sensitivity and accuracy for faster and more reliable diagnosis in emergencies. The test helps clinicians quickly identify heart attack and ...
A single high-sensitivity cardiac troponin T (hs-cTnT) test with findings below the level of detection, teamed with a nonischemic electrocardiogram (ECG), can identify patients with chest pain in the ...
Cardiac troponin T is a protein biomarker detectable with a blood test, and it is the preferred biomarker for determining cardiovascular risk. In a new study published in JAMA Cardiology, researchers ...
Basel, Switzerland - Roche Diagnostics received clearance this week from the FDA for the Elecsys ® Troponin T STAT test as an aid in the differential diagnosis of acute coronary syndrome, for risk ...
Assisted by the HEART score, emergency physicians appear to be able to safely discharge patients with chest pain after just one negative conventional troponin test result, a retrospective cohort study ...
Using more sensitive and frequent repeat testing of a blood test that indicates heart injury to guide the treatment of low-risk patients with symptoms of a possible heart attack resulted in patients ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results